Category: OIG Compliance Program Guidance for Pharmaceutical Manufacturers

II. Compliance Program Elements D. Conducting Effective Training and Education

The proper education and training of officers, directors, employees, contractors, and agents, and periodic retraining of personnel at all levels are critical elements of an...

CLICK FOR MORE

II. Compliance Program Elements C. Designation of a Compliance Officer and a Compliance Committee

1. Compliance Officer Every pharmaceutical manufacturer should designate a compliance officer to serve as the focal point for compliance activities.12 This responsibility may be the individual’s...

CLICK FOR MORE

II. Compliance Program Elements B. Written Policies and Procedures (Page 1)

In developing a compliance program, every pharmaceutical manufacturer should develop and distribute written compliance standards, procedures, and practices that guide the company and the conduct...

CLICK FOR MORE

II. Compliance Program Elements A. The Basic Compliance Elements

The OIG believes that every effective compliance program must begin with a formal commitment by the pharmaceutical manufacturer’s board of directors or other governing body....

CLICK FOR MORE
Contact Us

Contact Us

The more detailed the response, the more likely it is that we will be able to evaluate and determine if your potential False Claims Act case falls within our case requirements. If it does, WE WILL RESPOND TO YOU WITHIN 24 HOURS. (Names of potential defendants are not necessary at this point, should you feel more comfortable omitting them.) By law, all communications to us are 100% confidential.

Please enable JavaScript in your browser to complete this form.
No. of Employees at the Company?


Please read the following statement and then click “Send Form”:

Any response to your e-mail will be solely to communicate about our possible representation of you under the qui tam provisions of the False Claims Act. All e-mails submitted to us, whether we take your case or not, are 100% confidential. If we do not respond to your e-mail, then you have communicated information which we cannot address because it appears to fall outside of the False Claims Act or our case requirements.